studies:

Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025

March 01, 2025 12:45 ET  | Source: Celldex Therapeutics, Inc. - Greatly improved patient quality of life and reduced disease…

2 weeks ago

Berlin Heals Holding AG Successfully Raises Over 7Million CHF Round for Initiating First Studies of New Less Invasive Approaches

ZUG, Switzerland, Feb. 18, 2025 /PRNewswire/ -- Berlin Heals Holding AG, a late stage MedTech start up, has developed a…

4 weeks ago

Publications from all previous Olympic Games in Italy digitised by the Olympic Studies Centre

06 February 2025 - To celebrate the one-year countdown to the Olympic Winter Games Milano Cortina 2026, the Olympic Studies Centre (OSC) is not…

1 month ago

Axtria Unveils New US and Global Incentive Compensation Benchmarking Studies: Insights That Drive Life Sciences Success

Key Trends, Metrics, and Best Practices Unveiled to Optimize Incentive Strategies and Drive Performance in Life Sciences BERKELEY HEIGHTS, N.J.,…

3 months ago

Axtria Unveils New US and Global Incentive Compensation Benchmarking Studies: Insights That Drive Life Sciences Success

Key Trends, Metrics, and Best Practices Unveiled to Optimize Incentive Strategies and Drive Performance in Life Sciences BERKELEY HEIGHTS, N.J.,…

3 months ago

Axtria Unveils New US and Global Incentive Compensation Benchmarking Studies: Insights That Drive Life Sciences Success

Key Trends, Metrics, and Best Practices Unveiled to Optimize Incentive Strategies and Drive Performance in Life Sciences BERKELEY HEIGHTS, N.J.,…

3 months ago

Axtria Unveils New US and Global Incentive Compensation Benchmarking Studies: Insights That Drive Life Sciences Success

Key Trends, Metrics, and Best Practices Unveiled to Optimize Incentive Strategies and Drive Performance in Life Sciences BERKELEY HEIGHTS, N.J.,…

3 months ago